Zhang Lab
 
 

brain development and disorders

 
 
2019-08-23 11.54.05.jpg

The Zhang lab studies fundamental mechanisms of brain development with the ultimate goal of diagnosing and treating neurological disorders. Our current research centers on:

Neurogenesis in the cerebral cortex: The six-layered neocortex is an evolutionary feature in mammals. While diverse neuronal cell types have been identified in the brain, molecular mechanisms underlying the developmental production and specification of neuron subtypes remain to be fully understood. Recent single-cell transcriptome analyses (Ruan and Kang et al., 2021) from the lab uncovered temporal gene expression in apical and basal progenitors. Whether such dynamic gene expression regulate neural progenitor cell behavior remains unclear. We are interested in understanding how neural progenitors change their proliferation and differentiation capacity as well as other stereotypical cellular features over time using molecular, cellular, and genetic approaches. These studies will help to understand mechanisms of neurogenesis, neuronal migration (Zhang et al., 2009), and cell type specification in the neocortex.

mRNA isoforms and neural development: Alternative mRNA processing generates remarkable molecular diversity and in extreme cases enables a single gene to produce hundreds of different isoforms. What are the functions and mechanisms of alternative mRNA splicing and polyadenylation in the brain? Single-cell and genetic analyses from us and others start to uncover cell type-specific mRNA isoforms in developing human and mouse brains (Zhang et al., 2016) and human iPSC-derived cerebral organoids (Yang and Yang et al., 2023). We take advantage of single-cell and spatial transcriptomic data, and investigate cell type-specific polyadenylation in the brain (Kang et al., 2023). These analyses will enrich the annotation of mRNA forms, profile their dynamic expression during brain development, and facilitate the functional annotation of human mutations. We are studying functions of mRNA isoforms in neural development using genetic approaches and developing RNA deaminase-based recording methods to investigate the mechanisms of protein-RNA interaction (Ruan et al., 2023).

Neurodevelopmental disorders — genetic discovery, pathogenic mechanism, and targeted therapy. DNA mutations that affect brain development can cause congenital diseases such as autism and epilepsy. We are interested in understanding the genetic variations and pathogenic mechanisms of neurodevelopmental disorders (Qi et al., 2022; Zhang et al., 2014). We are particularly interested in the functions of alternative splice isoforms and their roles in neuronal gene regulation and disease pathogenesis. On the other hand, redirecting splicing has been increasingly recognized as a promising approach to treat neurological disorders since the successful development of splice-switching oligonucleotide for spinal muscular atrophy. Our molecular, genetic, and developmental biology studies of mRNA isoforms will generate unique insights into their therapeutic potential. As an example, our recent work suggests that redirecting alternative splicing alleviates SYNGAP1 haploinsufficiency in models of human diseases (Yang and Feng et al., 2023).

At the University of Chicago, we work closely with labs within the Department of Human Genetics which has unusual strength in genetics, genomics, and computational biology. We share strong interest and collaborate with colleagues in neuroscience, statistics, developmental biology, systems and RNA biology, and pediatrics. We seek to gain insights into fundamental mechanisms of brain development and gene regulation.

Our works are supported by:

 
NIH-NIMH-logo.png
SFARI.jpg
DP2.jpg